logo
Plus   Neg
Share
Email

Lennox International Lowers FY19 Outlook - Quick Facts

While reporting its second-quarter financial results on Monday, Lennox International Inc. (LII) lowered its financial outlook for fiscal 2019.

For fiscal 2019, Lennox now forecasts adjusted earnings per share from continuing operations in a range of $11.30 to $11.90, down from the prior range of $12.00 to $12.60 per share.

The company also lowered its outlook for full-year adjusted revenue growth to a range of 2 percent to 5 percent, from the prior range of 3 percent to 7 percent growth.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $12.29 per share for the year on revenue growth of 2.00 percent to $3.89 billion. Analysts' estimates typically exclude special items.

"Slower moving shipments in the industry due to adverse weather has slowed regaining market share following the tornado and extends our recovery timeline to include the fourth quarter," Chairman and CEO Todd Bluedorn said.

However, Lennox reiterated its guidance for stock repurchases of $400 million in 2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the fourth quarter on Tuesday, Lockheed Martin Corp. (LMT) initiated earnings outlook for the full-year 2020, while boosting annual net sales outlook. For fiscal 2020, the company now expects earnings in a range of $23.65 to $23.95 per share. Net sales are now... Pfizer Inc. (PFE) reported that its fourth-quarter adjusted earnings per share declined 13 percent year-over-year to $0.55. On average, 11 analysts polled by Thomson Reuters expected the company to report profit per share of $0.57, for the quarter. Analysts' estimates typically exclude special items.... Practice Fusion Inc., a cloud-based electronic health record or EHR platform, agreed to pay $145 million to resolve criminal and civil investigations relating to its EHR software, the U.S. Department of Justice said in a statement. The company allegedly received kickbacks for increasing opioid prescriptions.
RELATED NEWS
Follow RTT
>